ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP22

Patients Raising Awareness for Patients – A Collaborative Partnership Between Take a Pain Check Foundation and Canadian Arthritis Patient Alliance

Natasha Trehan1 and Laurie Proulx2, 1Take a Pain Check Foundation, Markham, ON, Canada, 2Canadian Arthritis Patient Alliance, Ottawa, ON, Canada

Meeting: ACR Convergence 2022

Keywords: education, patient, Juvenile idiopathic arthritis, mental health, Pediatric rheumatology, Social support

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Patient Perspectives Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Juvenile Idiopathic Arthritis is a chronic disease that affects a child’s school life and relationships, creating social isolation for youth and young adults. Take a Pain Check Foundation and the Canadian Arthritis Patient Alliance are patient-led and managed. While both organizations focus on supporting people with rheumatic conditions, TAPC focuses specifically on empowering youth with rheumatic diseases. We will describe the efforts of these two organizations as they work collaboratively to support youth and increase awareness of the unique challenges of young people living with Juvenile Idiopathic Arthritis.

Intervention: TAPC and CAPA both collaborate through informal and formal meetings, advice, podcast episodes, blog posts, and co-hosting events. Information is shared from both groups on various social media channels to engage with youth living with arthritis. We have jointly developed and executed Instagram Live events to support young people with JIA; we engaged youth in the planning and execution of these events. This campaign consisted of CAPA and TAPC hosting two Instagram Live events: “Growing Up with Juvenile Arthritis” and “Exploring Self-Advocacy in Juvenile Arthritis”. Both discussions focused on personal experiences with chronic illness, challenges of speaking up as a young person, and ways that these individuals worked to become advocates for themselves.

Maintenance: TAPC and CAPA are growing and have reached a considerable Canadian and international following on social media. Collaboration has expanded the reach of TAPC and CAPA through a novel approach to engaging directly with youth communities. The latest event reached 368 people – 123 being followers and 245 being non-followers, with continued viewing after the event on Instagram, Facebook, and YouTube. Participants of the events all indicated that they enjoyed the event when giving feedback on our polls. The collaboration has been successful in creating a greater sense of community and understanding as we work towards a common goal of increasing patient knowledge and confidence in decision making.

Quality of Life: TAPC and CAPA have impacted the lives of several individuals diagnosed with rheumatic diseases as noted by the following people living with JIA:

“I really enjoyed participating in the Instagram Live event…Sharing my experiences about self-advocacy made me realize how much I’ve learned and grown since I began my advocacy journey…it reaffirmed the importance of community and learning from one another in disability justice work.”

“Speaking on self-advocacy was a fantastic way to share my lived experience and directly deliver actionable tips and advice to the arthritic community! As a disability advocate, opportunities like this build networks and relationships that continue after the event to strengthen our community.”


Disclosures: N. Trehan, Pfizer, AbbVie/Abbott; L. Proulx, AbbVie/Abbott, GlaxoSmithKlein(GSK), UCB, Janssen.

To cite this abstract in AMA style:

Trehan N, Proulx L. Patients Raising Awareness for Patients – A Collaborative Partnership Between Take a Pain Check Foundation and Canadian Arthritis Patient Alliance [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/patients-raising-awareness-for-patients-a-collaborative-partnership-between-take-a-pain-check-foundation-and-canadian-arthritis-patient-alliance/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-raising-awareness-for-patients-a-collaborative-partnership-between-take-a-pain-check-foundation-and-canadian-arthritis-patient-alliance/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology